Future directions in cardiovascular pharmacology: examples from the Renin-Angiotensin system.
Diz
Debra I
DI
Hypertension & Vascular Research Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. ddiz@wfubmc.edu
D000804:Angiotensin II / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000808:Angiotensinogen / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000503:physiopathology; D002319:Cardiovascular System / Q000187:drug effects*; D006801:Humans; D004364:Pharmaceutical Preparations; D012083:Renin / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D000092502:Renin Inhibitors
D000804:Angiotensin II; D000806:Angiotensin-Converting Enzyme Inhibitors; D000808:Angiotensinogen; D004364:Pharmaceutical Preparations; D012083:Renin; D000092502:Renin Inhibitors